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Plasma ultrafiltration during a primary urine formation in the glomerulus is a central
function of the kidneys. This process is associated with the anatomical region of the
kidney, which is composed of a basement membrane with highly specialized epithelial
cells called podocytes.
1 As a part of the glomerular filtration barrier, the slict diagram (SD)
is thought to function as a filter that is size-selective. In the nephrotic syndrome, the
normal podocyte substructure is lost; the effacement of podocyte foot processes results in a
massive proteinuria.
2,3 During the development of the nephrotic syndrome, this elaborate
morphology of the podocyte is dramatically altered, resulting in changes such as cell-
swelling, retraction, spreading of the foot processes, vacuole formation, formation of
occluding junctions with displacement or disruption of the slit diaphragms, and foot
process detachment from the glomerular basement membrane.
4-8 The cellular and
molecular changes that occur within the podocytes have been identified by the detection of
mutations in several genes encoding podocyte proteins, including CD2AP, nephrin and
podocin.
9-11 Here, we selected podocin, a component of the glomerular filtration barrier, as
a target for the yeast 2-hybrid system.
Podocin is an integral membrane protein with a single membrane domain that forms a
hairpin-like structure which places both the N- and C-termini in the cytosol. As a membrane
protein, it is almost exclusively expressed in a subset of highly specialized kidney epithelial
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complex in the podocyte foot processes. Furthermore, it is a
constituent of detergent-insoluble microdomains and has been
shown to interact with another raft-associated podocyte proteins,
CD2-associated protein (CD2AP) and nephrin.
12 Hence, podocin
may act as a scaffolding protein in the podocyte lipid rafts,
recruiting nephrin and CD2AP to these microdomains. Podocin
has been shown to play a major role in glomerular permeability;
mutations in this gene result in early onset nephrotic syndrome.
Therefore, we screened a mouse kidney complementary DNA
(cDNA) library to identify proteins that interact with podocin in
nephrotic syndrome.
Amplification of the podocin genomic sequence from the
mouse kidney
A frozen mouse kidney tissue sample (100 mg) was homogeniz-
ed in TRIZOL reagent (Gibco, Carlsbad, CA, USA), and total
RNA was then isolated by addition of a mixture containing
chloroform, isopropyl alcohol and 75% ethanol solution. Using
the Omniscript Reverse Transcription kit (Qiagen, Hilden,
Germany), cDNA was synthesized with total RNA (1 µg) as the
starting template. To amplify the podocin gene from the mouse
kidney cDNA, podocin primers were designed (EcoR I-
containing forward primer 5’-GGAATTCATGGACAGC
AGG-3’ and BamH I-containing reverse primer 5’-
CGGGATCCCTAACATAGGAGA-3’) based on a homology
search, and cDNA and primers were added to the Polymerase
Chain Reaction (PCR) PreMix kit (iNtRon, Seongnam, Korea).
PCR conditions were as follows: 1 cycle of 95˚C for 3 minutes,
30 cycles of 95˚C for 30 seconds, 57˚C for 30 seconds, and
72˚C for 80 seconds followed by one cycle of 72˚C for 7
minutes. The PCR product was run on a 1% agarose gel
containing ethidium bromide, and then visualized under
ultraviolet (UV) light. 
Cloning and sequencing of the mouse podocin
Amplified PCR products eluted from agarose gel were obtained
using PCRquick-spin
TM (iNtRon). The purified PCR product
and the pGBKT7 vector were cut with the restriction enzymes,
EcoR I and BamH I (Roche, Mannheim, Germany), at 37˚C for
1 h, respectively. They were ligated using T4 DNA Ligase
(Roche) for 16 h at 16˚C. The resulting construct, pGBKT7 +
podocin, was transformed to an ECOS competent cell (DH5α)
by heat shock as described previously.
13 Some colonies selected
from the plate were cultured in 5 mL of Luria broth (LB) with
100 µg/mL ampicillin for 16 hours at 37˚C and extracted using
the Plasmid DNA-spin
TM purification kit (iNtRon). After adding
the restriction enzymes to the eluted plasmid, automated DNA
sequencing was performed to identify plasmids with the
podocin gene. The BLASTN algorithm was applied to search
the National Center for Biotechnology Information (NCBI)
non-redundant nucleotide database.
Yeast transformation
Using the lithium acetate (LiAc) -mediated yeast transform-
ation protocol (Clontech, Palo Alto, CA, USA), the bait plasmid,
pGBKT7-podocin, was transformed into the yeast strain
AH109, and then spread out on a SD/-Trp/-Ura plate. The
colonies that appeared on the SD/-Trp/-Ura plate were cultured
in SD/-Trp/-Ura media and confirmed to produce AH109/
pGBKT7-podocin by colony PCR. The mouse kidney cDNA
library (normal, whole kidneys pooled from 200 BALB/c, ages
8-12 weeks) was then transformed into the AH109/pGBKT7-
podocin, and the amplified yeast co-transformants were plated
on a SD/-Trp/-Leu plate (low stringency). To screen for positive
clones that interact with podocin, the colonies plated at high
density on the SD/-Trp/-Leu plate were scraped off and then
transferred to the SD/-Trp/-Leu/-His plate (medium stringency).
Then, the colonies that appeared on the SD/-Trp/-Leu/-His plate
were transferred to the SD/-Trp/-Leu/-His/Xα-Gal plate.
Analysis and verification of the putative clones
The positive clones that were blue on the SD/-Trp/-Leu/-His/X-
α-Gal plate were lysed in 200 µL of lysis buffer [0.1 M Tris-
HCl (pH 8.0), 50 mM EDTA, 1% SDS] and 200 µL of phenol :
chloroform : isoamyl alcohol, and vortexed at the highest speed
for 5 min. The debris was removed by centrifugation at 14,000
rpm for 10 minutes. The aqueous (upper) phase was transferred
to a fresh tube, and 3M acetate and 100% ethanol were added.
The sample was incubated at -70˚C or in a dry-ice/ethanol bath
for 1 h and centrifuged at 14,000 rpm for 10 minutes. The
pellets were washed with 1 mL of 70% ethanol and dried at
room temperature. The pellet was resuspended in 20 µL of
H2O. The positive plasmids were transformed into Escherichia
coil (E. coil), by heat shock. To select for transformants
containing only the AD/library plasmid, the yeast-purified
plasmids were plated on LB medium containing ampicillin.
The plasmids, containing the pACT2-specific inserts purified
from the Escherichia caoli (E. coil), were digested with Hind
III and analyzed by agarose/EtBr gel electrophoresis. After the
inserts with variant patterns were selected, they were sequenced
and then the sequences were entered into the program at the
website http://www.ncbi.nlm.nih.gov/BLAST to perform a
BLAST analysis.
Amplification of the podocin gene and cloning
Using the primers with mouse nephrosis 2 homology, NPHS
2, the podocin gene was successfully amplified to obtain the
1,158 bp predicted fragment by PCR. Purified PCR product
and pGBKT7 were ligated and transformed into the E. coli
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MATERIALS AND METHODS
RESULTSstrain DH5α by heat shock. By adding the restriction enzymes,
EcoR I and BamH I, the resulting plasmids with the target
gene were divided into 2 bands, the insert podocin and the
vector pGBKT7 (Fig. 1). These products were sequenced and
confirmed to be the podocin gene by the BLASTN algorithm.
Yeast 2-hybrid screening
The podocin bait (called pGBKT7-podocin) used in the yeast 2-
hybrid system contained the full-length cDNA fused in-frame
with the GAL4 DNA-binding domain of pGBKT7. The
pGBKT7-podocin was first transformed into AH109 by the
lithium acetate-mediated method. To confirm the transfor-
mation, colony PCR was performed with a podocin primer, and
confirmed to be the size of podocin on the agarose gel (Fig. 2).
To screen proteins interacting with podocin, the mouse kidney
cDNA library which contained the GAL4 activation domain
fused into random cDNA was transformed into the AH109/
pGBKT7-podocin and spread onto the SD/-Trp/-Leu plate (low
stringency). After the incubation of the plates at 30˚C until
colonies appeared, there were several clones at high density on
the SD/-Trp/-Leu plate (Fig. 3A). This environment provided
an initial phase of growth that maximized the plasmid copy
number, which resulted in higher levels of the fusion protein.
Clones on the SD/-Trp/-Leu plate represented weak or transient
interaction of the cDNA library (AD/library plasmid) with the
AH109/pGBKT7-podocin. To screen for the actual putative
proteins, the clones on the SD/-Trp/-Leu plate were scraped off
and then transferred to the SD/-Trp/-Leu/-His plate (medium
stringency). After this step, at least 1.5-3 times the number of
independent clones in the library was screened (Fig. 3B).
Subsequently, colonies on the SD/-Trp/-Leu/-His plate were
transferred to the SD/-Trp/-Leu/-His/X-α-gal plate (Fig. 4). As
a final step to identify the AD fusion proteins that interact with
Screening for Proteins Interacting with Podocin
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Fig. 2. Colony PCR from the pGBKT7-podocin transformed into the AH109 by the
lithium acetate-mediated method. By cPCR using a podocin primer, the colonies on
the SD/-Ura plate were confirmed to be podocin. PCR, polymerase chain reaction;
cPCR, colony polymerase chain reaction.
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Fig. 1. Confirmation of the recombinant bait expression by restriction enzyme
(REs), EcoR I and BamH I, and digestion. The podocin and vector that had been
transformed to DH5α appeared on the LB plate. After grown in the LB medium,
the resulting plasmid was divided into 2 bands, podocin and vector, by the REs.
(Marker: 0.25-10 KB DNA ladder marker.)
Fig. 3. Mouse kidney cDNA library that was transformed into AH109/pGBKT7-
podocin. (A) Clones that appeared on the SD/-Trp/-Leu plate (low stringency).
(B) Putative clones that were transferred to the SD/-Trp/-Leu/-His plate
(medium stringency). The copy number of independent clones in the library was
screened at least 1.5-3 times at this step. CDNA, complementary DNA.
Fig. 4. The putative proteins predicted to interact with podocin. (A) On the SD/-
Trp/-Leu/-His/X-αgal plate, the blue clones were the AD/library plasmids mated
with podocin. (B) Without X-α-gal.
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Fig. 5. Rescue AD/Library plasmids via transformation of E. coli. The yeast-
purified plasmid DNA was transformed into E. coli and plated on LB medium
containing ampicillin. Then, the plasmids were digested with Hind III and
resulted in various patterns such as (A), (B), (C), and (D).
AB
CDpodocin, all false positive interactions were virtually eliminated
by this screen, however, the low-affinity protein interactions
may have been missed. Clones that were blue on the SD/-Trp/-
Leu/-His/X-α-gal plate were thought to be the result of AD/
library plasmids mated with the plasmids encoding the
AH109/pGBKT7-podocin (Fig. 4A). To identify them, they
were cultured in SD/-Trp/-Leu/-His media and isolated by
following the instructions in the manual (see the methods
section). The plasmids isolated from the positive clones were
transformed into E. coli by heat shock. After eluted from the
purification kit, the plasmids digested with Hind III demon-
strated different patterns on the agarose/EtBr gel (Fig. 5).
Sequencing of putative positive clones and BLAST analysis
The plasmids with the variant patterns were sequenced and
analyzed using the BLAST software available on the internet. The
data of the sequencing results are reported in Table 1. We identified
12 clones that were plasmids which were screened by the yeast 2-
hybrid system and only 4 of the 12 clones were found to be
associated with the podocyte. The biology of the 4 clones identified
as plasmids that interact with podocin will require a further study. 
The SD is primarily responsible for size selectivity of the
glomerular filter.
14,15 Previous genetic studies revealed that
nephrin, CD2AP and podocin are required for normal filtration
function of the SD.
10,16-19 They are associated with the lipid rafts
of the SD, and podocin not only co-localizes with but also
interacts with CD2AP and nephrin. Podocin plays a major role
in glomerular permeability; it’s mutations result in early onset
nephrotic syndrome in humans.
9,20 A number of mutations of
the podocin gene have been shown to cause the autosomal
recessive, steroid-resistant nephrotic syndrome, characterized
by resistance to steroid therapy and rapid progression to end-
stage renal disease, resulting in the need for organ transplanta-
tion.
21,22 This suggests a regulatory role for podocin in determin-
ing glomerular permeability. 
Here, we identified proteins that interact with podocin using
the yeast 2-hybrid system. The podocin gene of the mouse
kidney was amplified by PCR and isolated by cloning. The
plasmid was transformed into the AH 109, yeast strain, where
the mouse kidney cDNA library was then transformed. The AH
109 transformants were screened via high-, medium- and low-
stringency steps. These selection steps provided less stringent
screens that increased the number of false positives and the
more stringent screens that decreased the likelihood of false
negatives. Because the high stringency media provided a step to
eliminate false positive interactions, the resulting blue clones
screened by a final step were predicted to be candidate proteins
for interaction with podocin. Among the clones identified by
sequencing, we selected only 4 putative proteins by searching
for a relationship between podocin and candidates; they were
kinesin, glutathione peroxidase 3 (Gpx3), sterol carrier protein
2 (Scp2) and cathepsin H (Ctsh). 
However, nephrin, CD2AP and some other podocyte-specific
proteins that associate with podocin were not screened through
the yeast 2-hybrid system. As a tool of the genomic approach,
the yeast 2-hybrid system indicates which protein encoded in
the genome of interest is expressed for the examination of
mutual interactions. Furthermore, it detects not only transient
and unstable interactions, but also predicts possible interactions.
Therefore, it is currently so well-established to be used in a
genomewide scale.
23 On the other hand, this system has various
limitations inherent to its method itself. According to 2
studies,
24,25 the data obtained by this system did not largely
overlap with each other, and failed to recapitulate the 2-hybrid
interactions that are identified in conventional studies. In
experiments that identify a protein-protein interaction, the
Soo Jin Park, et al.
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DISCUSSION
Table 1. The BLAST Results of the Positive Clones Predicted to Interact with the Mouse Kidney cDNA Library Using the pGBKT7-
BD/podocin Plasmid as Bait
No.* Identification Physical condition
a-1 Mus musculus G elongation factor, mitochondrial 1 (Gfm1) Intracellular
a-2 Mus musculus kinesin family member 16B (Kif16b)
� Intracellular
a-3 Mus musculus signal recognition particle 68 (Srp68) Intracellular
b-1 Mus musculus glutathione peroxidase 3 (Gpx3)
� Extracellular
b-2 Mus musculus sterol carrier protein 2, liver (Scp2)
� Intracellular
b-3 Mus musculus galactosamine (N-acetyl)-6-sulfate sulfatase (Galns) Membrane protein
c-1 Mus musculus bone marrow stromal cell antigen 2 (Bst2) Membrane protein
c-2 Mus musculus similar to mKIAA1021 protein (LOC100045280) Unknown
c-3 Mus musculus solute carrier family 22 (organic anion transporter), member 6 (Slc22a6) Intracellular
d-1 Mus musculus N-myc downstream regulated gene 1 (Ndrg1) Intracellular
d-2 Mus musculus solute carrier family 34 (sodium phosphate), member 1 (Slc34a1) Intracellular
d-3 Mus musculus cathepsin H (Ctsh)
� Intra/Extracellular
*number of plasmids shown at Fig. 5.
�plasmids considered as proteins that interact with podocin.percentage of their false positive and false negative is 30-60 and
40-80, respectively.
24,25 The reasons for this small coverage are
insufficient depth of the screening, potential misfolding or
mutations interfering interactions and the use of full-length
proteins.
26,27 Therefore, we exists a possibility that nephrin,
CD2AP and some other podocyte-specific proteins were not
detected by this approach because of these reasons.
First, kinesin among the 4 putative proteins is a protein
related to the podocyte process. Podocyte formation is
mechanically dependent on microtubules (MT) that are
regulated by various microtubule-associated proteins (MAPs).
The podocyte processes posses MT with mixed polarity, plus-
end-distal and minus-end-distal. Minus-end distal MTs are
assembled in the centrosomes and then transported to
cytoplasmic processes such as podocyte.
28,29 In these processes,
short fragments of the minus-end-distal MTs are conveyed by a
kinesin-related motor protein, CHO1/MKLP1. CHO1/MKLP1
is a member of the kinesin superfamily
30 and is localized in a
punctuated pattern on the MTs, indicating the association of
CHO1/MKLP1 with the MTs in the podocyte processes.
31
Recent evidence suggested that CHO1/MKLP1 has a dual
function: the generation of force during mitosis
30 and transport
of the MTs in the dendrites.
31-34 Therefore, to establish the
mixed polarity of the MTs, the podocyte expresses
CHO1/MKLP1, which is essential for the formation of
podocyte processes. Based on these findings, we predict that
podocin may interact with kinesin, and that their interaction
may influence the formation of the podocyte processes.
Second, the development of nephrotic syndrome has been
associated with an early and transient induction of glomerular
reactive oxygen species (ROS),
35 a decrease in glomerular
antioxidant enzyme (AOE) activity
36 and the accumulation of
the products associated with oxidative damage to membranes
(lipid peroxides) in the renal cortex,
37 glomeruli
38,39 and urine.
37-39
The injection of puromycin aminonucleoside (PAN) into rats is
commonly used to cause the development of foot process
effacement and proteinuria.
8,40 PAN-induced podocyte injury is
mediated by ROS and modulated by podocyte antioxidant
defenses such as an induction of catalase, superoxide dismu-
tase, glutathione peroxidase and so forth.
41 Based on these
findings, it is hypothesized that glutathion peroxidase 3 (Gpx3),
a type of AOE, is related to the nephrotic syndrome and is
produced within podocytes. Therefore, we speculate that Gpx3
may have a connection with podocin.
Third, the kidney actively metabolizes lipophilic molecules.
Partial segments of nephrons absorb long-chain fatty acids
rapidly from the blood stream, synthesize prostanoids from
arachidonic acid in response to humeral factors and modulate
renal function.
42 Diet-induced or endogenous hyperlipidemia, in
animal models of glomerular injury, accelerates the progression
of glomerulosclerosis.
43 Cytosolic lipid-binding proteins (LBPs)
with low molecular masses (10-20 kDa), are capable of binding
lipophilic molecules and are thought to play an important role
in cell signaling pathways involving lipophilic molecules as
well as intracellular trafficking and lipid metabolism.
44,45 The
LBP family includes mainly the fatty acid binding protein
(FABP), acyl-CoA binding protein (ACBP), sterol carrier
protein 2 (Scp2), cellular retinol binding protein (CRBP), and
phosphatidylinositol transfer protein (PITP). Expression of the
messenger RNA (mRNA) for these proteins is variably
detected in rat glomeruli (RG) or rat mesangial cells (RMC).
46
These studies led us to infer that Scp2 detected by the yeast 2-
hybrid system may likely be linked to podocin in the podocytes. 
Finally, a podocyte damage is considered to be an important
factor for the development of glomerulosclerosis. Degradation
of the glomerular basement membrane (GBM) by proteinases
might be a potential mechanism involved in detachment because
of the impairment of the normal process between the podocytes
and the GBM. Increases in proteolytic activity may induce
degradation of the GBM, which plays an important role in the
progression of glomerulosclerosis. Glomerular endogenous
proteinases, as well as proteinases released from the glomerular
infiltrating cells are known to contribute to the degradation of
the GBM.
47-50 Recent studies demonstrated that glomeruli
contain several proteinases, most notably metalloporteinases
(MMPs) and cysteine proteinase, cathepsin L.
47,49 Cathepsin B,
H and L are representative cysteine proteinases found in
lysosomes.
51,52 These cysteine proteinases are thought to
mediate the generation of bioactive products from precursor
proteins.
51,53 The secretion of these proteinases is stimulated by
growth factors, some of which are known to contribute to the
development and progression of glomerulosclerosis.
54-56 The
activity of the proteinases secreted from the podocytes is
relevant to podocyte detachment, thereby contributing to the
development and progression of glomerular sclerosis since it
causes extracellular degradation of the GBM proteins.
57
Therefore, cathepsin H may also be involved in the degradation
of the GBM and associated with podocin. 
4 candidate proteins may play an important role in renal
physiology through their interaction with podocin. All of them
have been implicated in nephrosis and are affected by marked
podocyte changes. The fact that initiation of signal transduction
by the slit diaphragm is critical for podocyte integrity and
function reflects the importance of podocin to the structural
integrity of the slit diaphragm complex. It remains, however, to
be determined how podocin and its related proteins interact with
each other in vivo, and additional studies are needed to clarify
the relationship between podocin and the 4 candidate proteins
identified in this study. We are currently in a process to confirm
their physical interactions with podocin and clarify physiological
significance of their interactions in primary podocytes. We plan
to perform loss of function experiments using siRNA and gain
of function experiment in heterologous system.
In conclusion, this study is a worthwhile work which pre-
sented a possibility that the interaction with podocin and
candidates may cause the nephrotic syndrome.
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